Recombinant Human Cellular nucleic acid-binding protein (CNBP)

1. The authors report a previously unknown long noncoding RNA which, together with CNBP, is involved in the fine-tuned regulation of CCND1 mRNA stability, without which CCND1 exhibits, at most, partial expression. PMID: 29199958
2. [CCTG]n repeat expansion, differently from the DM1 mutation, does not influence the methylation status of the CNBP gene and other molecular mechanisms are involved in the pathogenesis of Myotonic Dystrophy type 2.. PMID: 29291944
3. RNA sequence preferences of unconventional RNA-binding proteins, Nudt21 and CNBP, has been described. PMID: 27956239
4. A second point is that DM mutations, although located in noncoding regions, may reduce the expression of mutant alleles, raising questions whether loss-of-function may contribute to the phenotype, or possibly impose a safety limit on knockdown therapies that create or aggravate a DMPK or CNBP deficiency state PMID: 28376341
5. CNBP is supporting translation by resolving stable structures on mRNAs. PMID: 28329689
6. A G-rich motif in the lncRNA Braveheart interacts with Cnbp to specify the cardiovascular lineage. PMID: 27618485
7. The cnbp overexpression rescued the Treacher Collins Syndrome phenotype in a dose-dependent manner by a reactive oxygen species-cytoprotective action that prevented the redox-responsive genes' upregulation but did not normalize the synthesis of ribosomal RNAs. PMID: 27711076
8. High CNBP expression is associated with Medulloblastoma. PMID: 26460945
9. CNBP overexpression caused increase of cell death and suppression of cell metastasis through its induction of G-quadruplex formation in the promoter of hnRNP K resulting in hnRNP K down-regulation PMID: 24594223
10. Arginine methylation of CNBP in the RG motif does not change the subcellular localization but regulates its RNA binding activity. PMID: 24726729
11. CNBP are novel antigens for SLE patients and the recognition of CNBP might be differentiated dependent on the level of arginine methylation. PMID: 23642268
12. suggested a new possibility of CNBP as a potential anti-cancer target based on CNBP's biological function in c-myc transcription PMID: 23774591
13. CNBP associates with the poly(A) binding protein and accumulates in stress granules. PMID: 23285195
14. The co-segregation of Myotonic dystrophy type 2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings for juvenile onset of myotonia in a 14-year-old female with Myotonic dystrophy type 2 and her affected mother PMID: 22407275
15. Myotonic dystrophy 2(autosomal dominant, multisystem disorder caused by a CCTG tetranucleotide repeat expansion located in intron 1 of the zinc finger protein 9 gene (ZNF9 gene) on chromosome 3q 21.3.) described in Israeli Jewish European ancestry. PMID: 22332444
16. CCTG repeat expansions in the CNBP gene are responsible for myotonic dystrophy type 2. PMID: 21204798
17. Study concludes that DM2 patients from the Netherlands, including a North-African family, harbor a common haplotype surrounding the ZNF9 gene. PMID: 21224892
18. These data suggest that Gis2 is functionally orthologous to ZNF9 and acts as a cap-independent translation factor. PMID: 21277287
19. ZNF9 expression in myotonic dystrophy type 2 patients is altered at multiple levels. PMID: 20971734
20. ZNF9 is abundantly expressed in human myofibres, where it is located in the sarcomeric I bands, and no modification of this pattern is observed in myotonic dystrophy type 2 muscles. PMID: 20102514
21. Data identify ZNF9 as a regulator of cap-independent translation and indicate that ZNF9 activity may contribute mechanistically to the myotonic dystrophy type 2 phenotype. PMID: 20174632
22. Six of seven of the Zn(2+) fingers from the CNBP protein can be used as substitutes for the Zn(2+) finger in the NH(2)-terminal position of HIV-1 nucleocapsid, and thus support virus replication PMID: 12857921
23. The proximal myotonic myopathy phenotype is associated with DM2-(CCTG)(n) expansion mutations. PMID: 15261229
24. In twenty-six individuals from a family with DM, the CCTG repeats in ZNF9 were found in normal range. PMID: 15476170
25. results show that a single nucleotide polymorphism located in the first intron of the ZNF9 gene is in linkage disequilibrium with the DM2 mutation PMID: 15652222
26. Results indicate that the (CCTG)n expansion in the ZNF9 intron does not appear to have a direct consequence on the expression of the gene itself. PMID: 16376058
27. the downstream molecular effects of a DM2 mutation are triggered by the accumulation of CCUG repeat tract alone and do not decrease ZNF9 expression at the mRNA or protein level PMID: 16624843
28. We present two first-degree relatives with an athletic clinical phenotype, pathological evidence of subsarcolemmal vacuolation, and molecular genetic confirmation of DM2(the molecular defect of the zinc finger protein 9 gene) PMID: 17068784
29. PCBP2 and ZNF9 stimulate translation of the ornithine decarboxylase internal ribosomal entry site . PMID: 17327219
30. These data contribute to the clinical and molecular correlation of ZNF9 gene short expansion in myotonic dystrophy. PMID: 18804219
31. Validated occurrence of an unusual TG 3' splice site in intron 3. PMID: 17672918

Show More

Hide All

HGNC: 13164

OMIM: 116955

KEGG: hsa:7555

STRING: 9606.ENSP00000410769

UniGene: Hs.518249